Engrail Therapeutics

Engrail Therapeutics company information, Employees & Contact Information

We are a neuroscience company forging a new direction to reduce the enormous burden of diseases that impact the nervous system. At our core, we unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverage our flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization.

Company Details

Employees
36
Founded
-
Address
12750 High Bluff Drive, Suite 190, San Diego,california 92130,united States
Email
in****@****ail.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Engineer jobs.
HQ
San Diego, California
Looking for a particular Engrail Therapeutics employee's phone or email?

Engrail Therapeutics Questions

News

Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies - Business Wire

Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies Business Wire

Engrail Therapeutics Appoints Paul Cayer as Chief Financial Officer and Saira Ramasastry to Board of Directors - Yahoo Finance

Engrail Therapeutics Appoints Paul Cayer as Chief Financial Officer and Saira Ramasastry to Board of Directors Yahoo Finance

Engrail Therapeutics Initiates ENX-104 Clinical Program for - GlobeNewswire

Engrail Therapeutics Initiates ENX-104 Clinical Program for GlobeNewswire

Engrail’s precision psychiatry drugs get more buy in from venture investors - BioPharma Dive

Engrail’s precision psychiatry drugs get more buy in from venture investors BioPharma Dive

Engrail Therapeutics Acquires NeuroCycle Therapeutics - citybiz

Engrail Therapeutics Acquires NeuroCycle Therapeutics citybiz

Engrail Therapeutics initiates ENCALM trial of GAD therapy - Clinical Trials Arena

Engrail Therapeutics initiates ENCALM trial of GAD therapy Clinical Trials Arena

Engrail closes $157M series B, fueled by investors' renewed interest in neuropsychiatry - Fierce Biotech

Engrail closes $157M series B, fueled by investors' renewed interest in neuropsychiatry Fierce Biotech

Exclusive: Successful Biotech CEO Talks Scaling from Series A to $157M Series B - Fred Grier | Substack

Exclusive: Successful Biotech CEO Talks Scaling from Series A to $157M Series B Fred Grier | Substack

Engrail Raises $157M in Oversubscribed Series B to Move Neuro Pipeline Forward - BioSpace

Engrail Raises $157M in Oversubscribed Series B to Move Neuro Pipeline Forward BioSpace

Engrail raises $157M for pipeline of ‘de-risked’ mood disorder treatments - FirstWord Pharma

Engrail raises $157M for pipeline of ‘de-risked’ mood disorder treatments FirstWord Pharma

A quintet of CFO hires at Intra-Cellular, Engrail, Faron, Coherus and Element - BioCentury

A quintet of CFO hires at Intra-Cellular, Engrail, Faron, Coherus and Element BioCentury

Wilson Sonsini Advises NeuroCycle Therapeutics on Acquisition by Engrail Therapeutics - Wilson Sonsini

Wilson Sonsini Advises NeuroCycle Therapeutics on Acquisition by Engrail Therapeutics Wilson Sonsini

Engrail raises $157 million in funding for anxiety meds sans the side effects - Mint

Engrail raises $157 million in funding for anxiety meds sans the side effects Mint

Engrail Therapeutics closes over-subscribed $157M Series B financing round for transformational therapies - BioSpectrum India

Engrail Therapeutics closes over-subscribed $157M Series B financing round for transformational therapies BioSpectrum India

Venture report: Mirador’s $400M launch; megarounds for Clasp, Capstan, Engrail - BioCentury

Venture report: Mirador’s $400M launch; megarounds for Clasp, Capstan, Engrail BioCentury

Engrail Therapeutics nabs $32M series A for CNS work - Fierce Biotech

Engrail Therapeutics nabs $32M series A for CNS work Fierce Biotech

Top Engrail Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant